InspireMD develops and commercializes medical devices for the treatment of carotid artery and other vascular diseases. The company's primary product is the CGuard carotid embolic prevention system, a mesh-covered self-expanding stent designed for carotid artery applications. The company also offers the CGuard Prime Stent System and the SwitchGuard neuroprotection system, which is used for transcarotid access and acute stroke treatment in patients with tandem lesions. A strategic agreement with the Jacobs Institute supports an early feasibility study of CGuard Prime for acute stroke applications.
The company operates through a distribution partnership model, selling its products via local partners across Europe, Latin America, the Middle East, and the Asia Pacific. InspireMD maintains headquarters in Miami, Florida, with 66 full-time employees. The company was founded in 2005 and trades on Nasdaq under the ticker NSPR.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-0.76 | $-0.76 | +7.3% | |
| 2023 | $-0.82 | $-0.82 | +65.1% | |
| 2022 | — | $-2.35 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — | |
| 2017 | — | — | — | |
| 2016 | — | — | — | |
| 2015 | — | — | — | |
| 2014 | — | — | — | |
| 2013 | — | — | — | |
| 2011 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-12 | 0001493152-25-009909 | SEC ↗ |
| 2023-12-31 | 2024-03-05 | 0001493152-24-008850 | SEC ↗ |
| 2022-12-31 | 2023-03-30 | 0001493152-23-009598 | SEC ↗ |
| 2021-12-31 | 2022-03-07 | 0001493152-22-006180 | SEC ↗ |
| 2020-12-31 | 2021-03-08 | 0001493152-21-005564 | SEC ↗ |
| 2019-12-31 | 2020-03-10 | 0001493152-20-003630 | SEC ↗ |
| 2018-12-31 | 2019-02-19 | 0001493152-19-002225 | SEC ↗ |
| 2017-12-31 | 2018-02-13 | 0001493152-18-001974 | SEC ↗ |
| 2016-12-31 | 2017-02-16 | 0001493152-17-001710 | SEC ↗ |
| 2015-12-31 | 2016-03-28 | 0001615774-16-004660 | SEC ↗ |
| 2014-12-31 | 2015-03-12 | 0001144204-15-015698 | SEC ↗ |
| 2013-06-30 | 2013-09-17 | 0001144204-13-051239 | SEC ↗ |